GW Henssler & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$10.1M	Sell	22,763 -48	-0.2%	-$21.4K	0.54%	74
2025 Q1	$11.1M	Sell	22,811 -1,405	-6%	-$681K	0.63%	62
2024 Q4	$11.3M	Sell	24,216 -257	-1%	-$120K	0.65%	59
2024 Q3	$11.4M	Buy	+24,473	New	+$11.4M	0.64%	59